Lucía Bonet

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients†

Montserrat Laguno, Javier Murillas, Sergio Veloso et al. · Hepatology · 2008 · 111 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Differences in the Use and Opinions About New eHealth Technologies Among Patients With Psychosis: Structured Questionnaire

Lucía Bonet, Blanca Llácer, Miguel Hernández-Viadel et al. · JMIR Mental Health · 2018 · 45 citations · Full text

Medicine, Health Informatics, Psychiatry +11

Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.

Natalia Laufer, Montserrat Laguno, Iñaki Pérez et al. · PubMed · 2008 · 38 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

Javier Crespo, José Luís Calleja, Inmaculada Fernández et al. · Clinical Gastroenterology and Hepatology · 2017 · 32 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15